Review



mouse anti-human cd3ζ sc-1239  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Santa Cruz Biotechnology mouse anti-human cd3ζ sc-1239
    Dynamics of CARζ/CPR41BB T-cell activation and CARIS formation in comparison with CAR41BBζ cells. A, CARζ/CPR41BB cells ( n = 3 donors) demonstrated significantly lower IL-2 and IFN-γ release compared with CAR41BBζ cells at 24 hours of coculture with LN229-GBM cells, with CAR28ζ cells consistently showing the higher Th1 cytokine production. Data are shown as the mean ± SD. **, P < 0.000; ****, P < 0.0001; two-way ANOVA with the Tukey multiple comparisons test. B, Western blot analysis for CAR-phosphoCD3ζ (pCD3) in T cells in a resting state (maintained in culture with IL-7/IL-15). The pCD3 to <t>CD3</t> ratio is normalized to CARζ in each donor. *, P < 0.05; one-way ANOVA with the Tukey multiple comparisons test. C, Representative image capture showing the CARIS with tumor cell (LN229-GBM) and different CARζ/CPR41BB immune synapse parameters evaluated. Gating strategy is shown in the Supplementary Material. Spearman correlation ( D ) between the intensity of CAR and CPR at the CARIS and ( E ) between the intensity of actin and CPR at the CARIS, both assessed by imaging flow cytometry at 15, 30, and 60 minutes. F, CARζ/CPR41BB and CAR41BBζ cells show significantly higher percent (%) of F-actin at the CARIS compared with CARζ cells. ns, P > 0.5; **, P < 0.01; ***, P < 0.0001, two-way ANOVA with the Tukey post hoc test. Data are shown as the mean with 95% confidence interval (CI). G, CARζ/CPR41BB cells show significantly higher CPR intensity in the CARIS with WT LN229 GBM cells at 15, 30, and 60 minutes compared with conjugates with LN229-PD-L1 KO (Kruskal–Wallis and Wilcox pairwise). CPR intensity increased over time in both conditions. ns, not significant.
    Mouse Anti Human Cd3ζ Sc 1239, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti-human cd3ζ sc-1239/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    mouse anti-human cd3ζ sc-1239 - by Bioz Stars, 2026-02
    90/100 stars

    Images

    1) Product Images from "A Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances CAR T-cell Function"

    Article Title: A Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances CAR T-cell Function

    Journal: Cancer Research Communications

    doi: 10.1158/2767-9764.CRC-24-0125

    Dynamics of CARζ/CPR41BB T-cell activation and CARIS formation in comparison with CAR41BBζ cells. A, CARζ/CPR41BB cells ( n = 3 donors) demonstrated significantly lower IL-2 and IFN-γ release compared with CAR41BBζ cells at 24 hours of coculture with LN229-GBM cells, with CAR28ζ cells consistently showing the higher Th1 cytokine production. Data are shown as the mean ± SD. **, P < 0.000; ****, P < 0.0001; two-way ANOVA with the Tukey multiple comparisons test. B, Western blot analysis for CAR-phosphoCD3ζ (pCD3) in T cells in a resting state (maintained in culture with IL-7/IL-15). The pCD3 to CD3 ratio is normalized to CARζ in each donor. *, P < 0.05; one-way ANOVA with the Tukey multiple comparisons test. C, Representative image capture showing the CARIS with tumor cell (LN229-GBM) and different CARζ/CPR41BB immune synapse parameters evaluated. Gating strategy is shown in the Supplementary Material. Spearman correlation ( D ) between the intensity of CAR and CPR at the CARIS and ( E ) between the intensity of actin and CPR at the CARIS, both assessed by imaging flow cytometry at 15, 30, and 60 minutes. F, CARζ/CPR41BB and CAR41BBζ cells show significantly higher percent (%) of F-actin at the CARIS compared with CARζ cells. ns, P > 0.5; **, P < 0.01; ***, P < 0.0001, two-way ANOVA with the Tukey post hoc test. Data are shown as the mean with 95% confidence interval (CI). G, CARζ/CPR41BB cells show significantly higher CPR intensity in the CARIS with WT LN229 GBM cells at 15, 30, and 60 minutes compared with conjugates with LN229-PD-L1 KO (Kruskal–Wallis and Wilcox pairwise). CPR intensity increased over time in both conditions. ns, not significant.
    Figure Legend Snippet: Dynamics of CARζ/CPR41BB T-cell activation and CARIS formation in comparison with CAR41BBζ cells. A, CARζ/CPR41BB cells ( n = 3 donors) demonstrated significantly lower IL-2 and IFN-γ release compared with CAR41BBζ cells at 24 hours of coculture with LN229-GBM cells, with CAR28ζ cells consistently showing the higher Th1 cytokine production. Data are shown as the mean ± SD. **, P < 0.000; ****, P < 0.0001; two-way ANOVA with the Tukey multiple comparisons test. B, Western blot analysis for CAR-phosphoCD3ζ (pCD3) in T cells in a resting state (maintained in culture with IL-7/IL-15). The pCD3 to CD3 ratio is normalized to CARζ in each donor. *, P < 0.05; one-way ANOVA with the Tukey multiple comparisons test. C, Representative image capture showing the CARIS with tumor cell (LN229-GBM) and different CARζ/CPR41BB immune synapse parameters evaluated. Gating strategy is shown in the Supplementary Material. Spearman correlation ( D ) between the intensity of CAR and CPR at the CARIS and ( E ) between the intensity of actin and CPR at the CARIS, both assessed by imaging flow cytometry at 15, 30, and 60 minutes. F, CARζ/CPR41BB and CAR41BBζ cells show significantly higher percent (%) of F-actin at the CARIS compared with CARζ cells. ns, P > 0.5; **, P < 0.01; ***, P < 0.0001, two-way ANOVA with the Tukey post hoc test. Data are shown as the mean with 95% confidence interval (CI). G, CARζ/CPR41BB cells show significantly higher CPR intensity in the CARIS with WT LN229 GBM cells at 15, 30, and 60 minutes compared with conjugates with LN229-PD-L1 KO (Kruskal–Wallis and Wilcox pairwise). CPR intensity increased over time in both conditions. ns, not significant.

    Techniques Used: Activation Assay, Comparison, Western Blot, Imaging, Flow Cytometry



    Similar Products

    90
    Santa Cruz Biotechnology mouse anti-human cd3ζ sc-1239
    Dynamics of CARζ/CPR41BB T-cell activation and CARIS formation in comparison with CAR41BBζ cells. A, CARζ/CPR41BB cells ( n = 3 donors) demonstrated significantly lower IL-2 and IFN-γ release compared with CAR41BBζ cells at 24 hours of coculture with LN229-GBM cells, with CAR28ζ cells consistently showing the higher Th1 cytokine production. Data are shown as the mean ± SD. **, P < 0.000; ****, P < 0.0001; two-way ANOVA with the Tukey multiple comparisons test. B, Western blot analysis for CAR-phosphoCD3ζ (pCD3) in T cells in a resting state (maintained in culture with IL-7/IL-15). The pCD3 to <t>CD3</t> ratio is normalized to CARζ in each donor. *, P < 0.05; one-way ANOVA with the Tukey multiple comparisons test. C, Representative image capture showing the CARIS with tumor cell (LN229-GBM) and different CARζ/CPR41BB immune synapse parameters evaluated. Gating strategy is shown in the Supplementary Material. Spearman correlation ( D ) between the intensity of CAR and CPR at the CARIS and ( E ) between the intensity of actin and CPR at the CARIS, both assessed by imaging flow cytometry at 15, 30, and 60 minutes. F, CARζ/CPR41BB and CAR41BBζ cells show significantly higher percent (%) of F-actin at the CARIS compared with CARζ cells. ns, P > 0.5; **, P < 0.01; ***, P < 0.0001, two-way ANOVA with the Tukey post hoc test. Data are shown as the mean with 95% confidence interval (CI). G, CARζ/CPR41BB cells show significantly higher CPR intensity in the CARIS with WT LN229 GBM cells at 15, 30, and 60 minutes compared with conjugates with LN229-PD-L1 KO (Kruskal–Wallis and Wilcox pairwise). CPR intensity increased over time in both conditions. ns, not significant.
    Mouse Anti Human Cd3ζ Sc 1239, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti-human cd3ζ sc-1239/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    mouse anti-human cd3ζ sc-1239 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Becton Dickinson mouse anti-human cd3ζ antibody
    Dynamics of CARζ/CPR41BB T-cell activation and CARIS formation in comparison with CAR41BBζ cells. A, CARζ/CPR41BB cells ( n = 3 donors) demonstrated significantly lower IL-2 and IFN-γ release compared with CAR41BBζ cells at 24 hours of coculture with LN229-GBM cells, with CAR28ζ cells consistently showing the higher Th1 cytokine production. Data are shown as the mean ± SD. **, P < 0.000; ****, P < 0.0001; two-way ANOVA with the Tukey multiple comparisons test. B, Western blot analysis for CAR-phosphoCD3ζ (pCD3) in T cells in a resting state (maintained in culture with IL-7/IL-15). The pCD3 to <t>CD3</t> ratio is normalized to CARζ in each donor. *, P < 0.05; one-way ANOVA with the Tukey multiple comparisons test. C, Representative image capture showing the CARIS with tumor cell (LN229-GBM) and different CARζ/CPR41BB immune synapse parameters evaluated. Gating strategy is shown in the Supplementary Material. Spearman correlation ( D ) between the intensity of CAR and CPR at the CARIS and ( E ) between the intensity of actin and CPR at the CARIS, both assessed by imaging flow cytometry at 15, 30, and 60 minutes. F, CARζ/CPR41BB and CAR41BBζ cells show significantly higher percent (%) of F-actin at the CARIS compared with CARζ cells. ns, P > 0.5; **, P < 0.01; ***, P < 0.0001, two-way ANOVA with the Tukey post hoc test. Data are shown as the mean with 95% confidence interval (CI). G, CARζ/CPR41BB cells show significantly higher CPR intensity in the CARIS with WT LN229 GBM cells at 15, 30, and 60 minutes compared with conjugates with LN229-PD-L1 KO (Kruskal–Wallis and Wilcox pairwise). CPR intensity increased over time in both conditions. ns, not significant.
    Mouse Anti Human Cd3ζ Antibody, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti-human cd3ζ antibody/product/Becton Dickinson
    Average 90 stars, based on 1 article reviews
    mouse anti-human cd3ζ antibody - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology mouse anti-human cd3ζ mab sc-166435
    a Schematic representation of FcRH5-specific CAR expression construct. b The cytolytic activity of mock T or FcRH5 CAR-T cells against indicated target cells at various effector: target cell (E/T) ratios was determined by a 6-h luciferase-based cytolytic assay. Data represent Mean ± SD from three independent experiments. c Mock T or FcRH5 CAR-T cells were co-cultured with target cells for 24 h, and cell-free supernatants were harvested for evaluating IFN-γ, IL-2 and TNF-α secretion. Mean ± SD, n = 3 independent co-cultures, unpaired two-tailed t -test. d Mock T or FcRH5 CAR-T cells were labeled with eFlour-670 and co-cultured with equal number of target cells for 5 days, and the dilution of eFlour-670 fluorescence signal was determined to reflect cell division. The plots were gated on <t>CD3</t> + lymphocytes. The above experiments a-d were repeated with 2 different T cell donors. e Flow cytometric analysis of FcRH5 expression on CD138 + primary myeloma cells from three newly-diagnosed MM patients. Solid line represents staining with anti-FcRH5 mAb and dashed line represents staining with isotype control antibody. f The patient-derived myeloma cells were co-cultured with autologous mock T or FcRH5 CAR-T cells for 24 h, and cell-free supernatants were harvested for determination of IFN-γ secretion. Mean ± SD, n = 3 independent co-cultures, unpaired two-tailed Student t -test. g The patient-derived myeloma cells were labeled with eFlour-670 and co-cultured with autologous mock T or FcRH5 CAR-T cells at the E/T ratio of 5:1 for 6 h, and then cytolytic effect of T cells was determined by a flow cytometry-based assay. Mean ± SD, n = 3 independent co-cultures, two-tailed Student t test.
    Mouse Anti Human Cd3ζ Mab Sc 166435, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti-human cd3ζ mab sc-166435/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    mouse anti-human cd3ζ mab sc-166435 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Becton Dickinson mouse anti-human cd3ζ
    Assessing the oligomerization state and surface organization of various chimeric antigen receptors in the unstimulated CAR T cell membrane. ( a ) Western blot analysis of HER2.z, HER2.CD28.z, HER2.41BB.z and HER2.CD28.41BB.z CAR T cells. The membranes were probed for anti-human <t>CD3ζ.</t> ( b ) Spot intensities were quantified using ImageJ/Fiji, and the proportion of dimer/oligomer states was determined. ( c ) Representative raw and segmented AiryScan images of fluorescently tagged CARs. Clusters were segregated by watershedding and quantified. The scale bar represents 2 µm. ( d ) Total intensity of the apical membrane slices. ( e ) Average number of clusters per 10 µm 2 apical membrane surface. ( f ) Distribution of individual cluster areas. ( g ) Integrated intensity of individual clusters. The charts represent mean ± SEM; nHER2.z = 54, 4 donors; nHER2.CD28.z = 44, 3 donors; nHER2.41BB.z = 47, 4 donors; nHER2.CD28.41BB.z = 54, 4 donors; * p < 0.05, ** p < 0.01, *** p < 0.001.
    Mouse Anti Human Cd3ζ, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti-human cd3ζ/product/Becton Dickinson
    Average 90 stars, based on 1 article reviews
    mouse anti-human cd3ζ - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Becton Dickinson pe-labeled mouse-anti-human cd3ζ p-y142
    Assessing the oligomerization state and surface organization of various chimeric antigen receptors in the unstimulated CAR T cell membrane. ( a ) Western blot analysis of HER2.z, HER2.CD28.z, HER2.41BB.z and HER2.CD28.41BB.z CAR T cells. The membranes were probed for anti-human <t>CD3ζ.</t> ( b ) Spot intensities were quantified using ImageJ/Fiji, and the proportion of dimer/oligomer states was determined. ( c ) Representative raw and segmented AiryScan images of fluorescently tagged CARs. Clusters were segregated by watershedding and quantified. The scale bar represents 2 µm. ( d ) Total intensity of the apical membrane slices. ( e ) Average number of clusters per 10 µm 2 apical membrane surface. ( f ) Distribution of individual cluster areas. ( g ) Integrated intensity of individual clusters. The charts represent mean ± SEM; nHER2.z = 54, 4 donors; nHER2.CD28.z = 44, 3 donors; nHER2.41BB.z = 47, 4 donors; nHER2.CD28.41BB.z = 54, 4 donors; * p < 0.05, ** p < 0.01, *** p < 0.001.
    Pe Labeled Mouse Anti Human Cd3ζ P Y142, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pe-labeled mouse-anti-human cd3ζ p-y142/product/Becton Dickinson
    Average 90 stars, based on 1 article reviews
    pe-labeled mouse-anti-human cd3ζ p-y142 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    91
    Santa Cruz Biotechnology mouse anti human cd3ζ
    Dual peptide CAR-T cell design. (A) Diagram of the CAR construct designs. The E-28t28z and E-8t28z constructs use CD28 and CD8 as the hinge/transmembrane domains respectively, while both constructs employed CD28 for the co-stimulatory domain. The E-28t28z-tCD34 and E-8t28z-tCD34 constructs are identical to the E-28t28z and E-8t28z constructs but feature co-expression of truncated CD34 as an extracellular marker. (B) Diagram of a CAR-T cell with the different dual peptide-based constructs as the antigen-recognition domain. (C) CD34+ expression analysis by flow cytometry allows for a built-in quantification of transduction efficiency. (D) ELISA results displaying IFN-gamma secretion from CAR- or mock-transduced (GFP) T cells co-cultured overnight against T387 GSCs or cell-free media, **** = p < 0.0001. Values shown in the bar chart represent the average of two independent experiments. (E) <t>CD3ζ</t> western blotting with GAPDH as a housekeeping gene, used for additional support to confirm the presence or lack of the CAR following transduction. LTR, Long terminal repeat; S, signal peptide; P2A, Porcine teschovirus-1 2A self-cleaving peptide; tCD34, Truncated CD34.
    Mouse Anti Human Cd3ζ, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti human cd3ζ/product/Santa Cruz Biotechnology
    Average 91 stars, based on 1 article reviews
    mouse anti human cd3ζ - by Bioz Stars, 2026-02
    91/100 stars
      Buy from Supplier

    Image Search Results


    Dynamics of CARζ/CPR41BB T-cell activation and CARIS formation in comparison with CAR41BBζ cells. A, CARζ/CPR41BB cells ( n = 3 donors) demonstrated significantly lower IL-2 and IFN-γ release compared with CAR41BBζ cells at 24 hours of coculture with LN229-GBM cells, with CAR28ζ cells consistently showing the higher Th1 cytokine production. Data are shown as the mean ± SD. **, P < 0.000; ****, P < 0.0001; two-way ANOVA with the Tukey multiple comparisons test. B, Western blot analysis for CAR-phosphoCD3ζ (pCD3) in T cells in a resting state (maintained in culture with IL-7/IL-15). The pCD3 to CD3 ratio is normalized to CARζ in each donor. *, P < 0.05; one-way ANOVA with the Tukey multiple comparisons test. C, Representative image capture showing the CARIS with tumor cell (LN229-GBM) and different CARζ/CPR41BB immune synapse parameters evaluated. Gating strategy is shown in the Supplementary Material. Spearman correlation ( D ) between the intensity of CAR and CPR at the CARIS and ( E ) between the intensity of actin and CPR at the CARIS, both assessed by imaging flow cytometry at 15, 30, and 60 minutes. F, CARζ/CPR41BB and CAR41BBζ cells show significantly higher percent (%) of F-actin at the CARIS compared with CARζ cells. ns, P > 0.5; **, P < 0.01; ***, P < 0.0001, two-way ANOVA with the Tukey post hoc test. Data are shown as the mean with 95% confidence interval (CI). G, CARζ/CPR41BB cells show significantly higher CPR intensity in the CARIS with WT LN229 GBM cells at 15, 30, and 60 minutes compared with conjugates with LN229-PD-L1 KO (Kruskal–Wallis and Wilcox pairwise). CPR intensity increased over time in both conditions. ns, not significant.

    Journal: Cancer Research Communications

    Article Title: A Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances CAR T-cell Function

    doi: 10.1158/2767-9764.CRC-24-0125

    Figure Lengend Snippet: Dynamics of CARζ/CPR41BB T-cell activation and CARIS formation in comparison with CAR41BBζ cells. A, CARζ/CPR41BB cells ( n = 3 donors) demonstrated significantly lower IL-2 and IFN-γ release compared with CAR41BBζ cells at 24 hours of coculture with LN229-GBM cells, with CAR28ζ cells consistently showing the higher Th1 cytokine production. Data are shown as the mean ± SD. **, P < 0.000; ****, P < 0.0001; two-way ANOVA with the Tukey multiple comparisons test. B, Western blot analysis for CAR-phosphoCD3ζ (pCD3) in T cells in a resting state (maintained in culture with IL-7/IL-15). The pCD3 to CD3 ratio is normalized to CARζ in each donor. *, P < 0.05; one-way ANOVA with the Tukey multiple comparisons test. C, Representative image capture showing the CARIS with tumor cell (LN229-GBM) and different CARζ/CPR41BB immune synapse parameters evaluated. Gating strategy is shown in the Supplementary Material. Spearman correlation ( D ) between the intensity of CAR and CPR at the CARIS and ( E ) between the intensity of actin and CPR at the CARIS, both assessed by imaging flow cytometry at 15, 30, and 60 minutes. F, CARζ/CPR41BB and CAR41BBζ cells show significantly higher percent (%) of F-actin at the CARIS compared with CARζ cells. ns, P > 0.5; **, P < 0.01; ***, P < 0.0001, two-way ANOVA with the Tukey post hoc test. Data are shown as the mean with 95% confidence interval (CI). G, CARζ/CPR41BB cells show significantly higher CPR intensity in the CARIS with WT LN229 GBM cells at 15, 30, and 60 minutes compared with conjugates with LN229-PD-L1 KO (Kruskal–Wallis and Wilcox pairwise). CPR intensity increased over time in both conditions. ns, not significant.

    Article Snippet: The membranes were blocked with 5% milk and probed with mouse anti-human CD3ζ (Santa Cruz Biotechnology; sc-1239, RRID: AB_627020), mouse anti-human phosphoCD3ζ (BD Biosciences; 558402, RRID: AB_647307), and GAPDH (Cell Signaling Technology, 2118, RRID: AB_561053) mAbs followed by appropriate IRdye secondary antibodies (Li-Cor).

    Techniques: Activation Assay, Comparison, Western Blot, Imaging, Flow Cytometry

    a Schematic representation of FcRH5-specific CAR expression construct. b The cytolytic activity of mock T or FcRH5 CAR-T cells against indicated target cells at various effector: target cell (E/T) ratios was determined by a 6-h luciferase-based cytolytic assay. Data represent Mean ± SD from three independent experiments. c Mock T or FcRH5 CAR-T cells were co-cultured with target cells for 24 h, and cell-free supernatants were harvested for evaluating IFN-γ, IL-2 and TNF-α secretion. Mean ± SD, n = 3 independent co-cultures, unpaired two-tailed t -test. d Mock T or FcRH5 CAR-T cells were labeled with eFlour-670 and co-cultured with equal number of target cells for 5 days, and the dilution of eFlour-670 fluorescence signal was determined to reflect cell division. The plots were gated on CD3 + lymphocytes. The above experiments a-d were repeated with 2 different T cell donors. e Flow cytometric analysis of FcRH5 expression on CD138 + primary myeloma cells from three newly-diagnosed MM patients. Solid line represents staining with anti-FcRH5 mAb and dashed line represents staining with isotype control antibody. f The patient-derived myeloma cells were co-cultured with autologous mock T or FcRH5 CAR-T cells for 24 h, and cell-free supernatants were harvested for determination of IFN-γ secretion. Mean ± SD, n = 3 independent co-cultures, unpaired two-tailed Student t -test. g The patient-derived myeloma cells were labeled with eFlour-670 and co-cultured with autologous mock T or FcRH5 CAR-T cells at the E/T ratio of 5:1 for 6 h, and then cytolytic effect of T cells was determined by a flow cytometry-based assay. Mean ± SD, n = 3 independent co-cultures, two-tailed Student t test.

    Journal: Nature Communications

    Article Title: Chimeric antigen receptor T cells targeting FcRH5 provide robust tumour-specific responses in murine xenograft models of multiple myeloma

    doi: 10.1038/s41467-023-39395-4

    Figure Lengend Snippet: a Schematic representation of FcRH5-specific CAR expression construct. b The cytolytic activity of mock T or FcRH5 CAR-T cells against indicated target cells at various effector: target cell (E/T) ratios was determined by a 6-h luciferase-based cytolytic assay. Data represent Mean ± SD from three independent experiments. c Mock T or FcRH5 CAR-T cells were co-cultured with target cells for 24 h, and cell-free supernatants were harvested for evaluating IFN-γ, IL-2 and TNF-α secretion. Mean ± SD, n = 3 independent co-cultures, unpaired two-tailed t -test. d Mock T or FcRH5 CAR-T cells were labeled with eFlour-670 and co-cultured with equal number of target cells for 5 days, and the dilution of eFlour-670 fluorescence signal was determined to reflect cell division. The plots were gated on CD3 + lymphocytes. The above experiments a-d were repeated with 2 different T cell donors. e Flow cytometric analysis of FcRH5 expression on CD138 + primary myeloma cells from three newly-diagnosed MM patients. Solid line represents staining with anti-FcRH5 mAb and dashed line represents staining with isotype control antibody. f The patient-derived myeloma cells were co-cultured with autologous mock T or FcRH5 CAR-T cells for 24 h, and cell-free supernatants were harvested for determination of IFN-γ secretion. Mean ± SD, n = 3 independent co-cultures, unpaired two-tailed Student t -test. g The patient-derived myeloma cells were labeled with eFlour-670 and co-cultured with autologous mock T or FcRH5 CAR-T cells at the E/T ratio of 5:1 for 6 h, and then cytolytic effect of T cells was determined by a flow cytometry-based assay. Mean ± SD, n = 3 independent co-cultures, two-tailed Student t test.

    Article Snippet: The membrane was probed with mouse anti-human CD3ζ mAb (Santa Cruz, catalog number sc-166435, clone: E3, dilution:1:100) or GAPDH mAb (Biolegend, catalog number 649203, clone:FF26A/F9)) followed by incubation with a horseradish peroxidase–conjugated goat anti-mouse IgG antibody (Santa Cruz, catalog number sc-516102, dilution:1:1000) .

    Techniques: Expressing, Construct, Activity Assay, Luciferase, Cell Culture, Two Tailed Test, Labeling, Fluorescence, Staining, Control, Derivative Assay, Flow Cytometry

    a Experimental schematic: Male NOG mice aged 6–8 weeks were subcutaneously inoculated with 5 × 10 6 NCI-H929-CBR cells expressing click beetle red (CBR) luciferase on day −7, and were then intravenously infused with 5 × 10 6 mock T or FcRH5 CAR-T cells from two different donors ( n = 6 mice per group for each donor) when the tumors became palpable (day 0). b Representative tumor bioluminescence of NOG mice at different time points. c Graph showed the quantification of whole-body luminescence in NOG mice from each group at different time points with the lines connecting the mean values. Data shown are representative for results obtained in independent experiments with T-cell from 2 donors. Mean ± SD, n = 6 mice, unpaired two-tailed Student t test, d Kaplan–Meier curve for the overall survival of mice from different treatment group ( n = 12 mice per group). Log-rank (Mantel-Cox) test. e The percentage of T cells (gated on human CD45 + CD3 + ) in peripheral blood of NOG mice at different time points was determined by flow cytometric analysis. Data are representative of two independent experiments with T-cell from 2 donors ( n = 12 mice per group in total). Mean ± SD, unpaired two-tailed Student t test,.

    Journal: Nature Communications

    Article Title: Chimeric antigen receptor T cells targeting FcRH5 provide robust tumour-specific responses in murine xenograft models of multiple myeloma

    doi: 10.1038/s41467-023-39395-4

    Figure Lengend Snippet: a Experimental schematic: Male NOG mice aged 6–8 weeks were subcutaneously inoculated with 5 × 10 6 NCI-H929-CBR cells expressing click beetle red (CBR) luciferase on day −7, and were then intravenously infused with 5 × 10 6 mock T or FcRH5 CAR-T cells from two different donors ( n = 6 mice per group for each donor) when the tumors became palpable (day 0). b Representative tumor bioluminescence of NOG mice at different time points. c Graph showed the quantification of whole-body luminescence in NOG mice from each group at different time points with the lines connecting the mean values. Data shown are representative for results obtained in independent experiments with T-cell from 2 donors. Mean ± SD, n = 6 mice, unpaired two-tailed Student t test, d Kaplan–Meier curve for the overall survival of mice from different treatment group ( n = 12 mice per group). Log-rank (Mantel-Cox) test. e The percentage of T cells (gated on human CD45 + CD3 + ) in peripheral blood of NOG mice at different time points was determined by flow cytometric analysis. Data are representative of two independent experiments with T-cell from 2 donors ( n = 12 mice per group in total). Mean ± SD, unpaired two-tailed Student t test,.

    Article Snippet: The membrane was probed with mouse anti-human CD3ζ mAb (Santa Cruz, catalog number sc-166435, clone: E3, dilution:1:100) or GAPDH mAb (Biolegend, catalog number 649203, clone:FF26A/F9)) followed by incubation with a horseradish peroxidase–conjugated goat anti-mouse IgG antibody (Santa Cruz, catalog number sc-516102, dilution:1:1000) .

    Techniques: Expressing, Luciferase, Two Tailed Test

    a Experimental schematic: Male NOG mice aged 6–8 weeks were intravenously inoculated with 5 × 10 6 MM.1s-FcRH5-CBR cells on day −7, and were then treated with 5 × 10 6 mock T, FcRH5 CAR-T cells or BCMA CAR-T cells from two different donors ( n = 6 mice per group for each donor) on day 0. b Representative tumor bioluminescence of NOG mice at different time points. c Graph showed the quantification of whole-body luminescence in NOG mice from each group at different time points with the lines connecting means. Data shown are representative for results obtained in independent experiments with T-cell from 2 donors. Mean ± SD, n = 6 mice, One-way ANOVA with Dunnett’s correction for multiple comparison. d Kaplan–Meier curve for the overall survival of mice from different treatment group ( n = 12 mice per group). Log-rank (Mantel–Cox) test. e The percentage of T cells (gated on human CD45 + CD3 + ) in peripheral blood of NOG mice was determined by flow cytometric analysis. Data are representative of two independent experiments with T-cell from 2 donors ( n = 12 mice per group in total). Mean ± SD, One-way ANOVA with Dunnett’s correction for multiple comparison.

    Journal: Nature Communications

    Article Title: Chimeric antigen receptor T cells targeting FcRH5 provide robust tumour-specific responses in murine xenograft models of multiple myeloma

    doi: 10.1038/s41467-023-39395-4

    Figure Lengend Snippet: a Experimental schematic: Male NOG mice aged 6–8 weeks were intravenously inoculated with 5 × 10 6 MM.1s-FcRH5-CBR cells on day −7, and were then treated with 5 × 10 6 mock T, FcRH5 CAR-T cells or BCMA CAR-T cells from two different donors ( n = 6 mice per group for each donor) on day 0. b Representative tumor bioluminescence of NOG mice at different time points. c Graph showed the quantification of whole-body luminescence in NOG mice from each group at different time points with the lines connecting means. Data shown are representative for results obtained in independent experiments with T-cell from 2 donors. Mean ± SD, n = 6 mice, One-way ANOVA with Dunnett’s correction for multiple comparison. d Kaplan–Meier curve for the overall survival of mice from different treatment group ( n = 12 mice per group). Log-rank (Mantel–Cox) test. e The percentage of T cells (gated on human CD45 + CD3 + ) in peripheral blood of NOG mice was determined by flow cytometric analysis. Data are representative of two independent experiments with T-cell from 2 donors ( n = 12 mice per group in total). Mean ± SD, One-way ANOVA with Dunnett’s correction for multiple comparison.

    Article Snippet: The membrane was probed with mouse anti-human CD3ζ mAb (Santa Cruz, catalog number sc-166435, clone: E3, dilution:1:100) or GAPDH mAb (Biolegend, catalog number 649203, clone:FF26A/F9)) followed by incubation with a horseradish peroxidase–conjugated goat anti-mouse IgG antibody (Santa Cruz, catalog number sc-516102, dilution:1:1000) .

    Techniques: Comparison

    a Cytolytic activity of bispecific CAR-T cells and mono-specific CAR-T cells against indicated target cells was determined by the 6-h luciferase-based cytolytic assay. Mean ± SD, n = 3 independent co-cultures. b Bispecific CAR-T cells or mono-specific CAR-T cells were co-incubated with indicated target cells for 24 h, and cell-free supernatants were harvested for evaluating IFN-γ, IL-2 and TNF-α secretion. Mean ± SD, n = 3 independent co-cultures. Experiments of ( a , b ) were repeated with two different T cell donors. c Experimental schematic: Male NOG mice aged 6–8 weeks mice were subcutaneously inoculated with 5 × 10 6 NCI-H929-CBR cells expressing click beetle red (CBR) luciferase on day −7, and were then intravenously infused with 5 × 10 6 mock T, FcRH5 CAR-T, BCMA CAR-T or FcRH5/BCMA CAR-T cells from two different donors ( n = 6 mice per group for each donor) on day 0 when the tumors became palpable. d Representative tumor bioluminescence of NOG mice at different time points. e Graph showed the quantification of whole-body luminescence in NOG mice from each group at different time points with the lines connecting means. Data shown are representative for results obtained in independent experiments with T-cell from 2 donors. Mean ± SD, n = 6 mice per group, One-way ANOVA with Dunnett’s correction for multiple comparison. f Kaplan–Meier curve for the overall survival of mice from different treatment group ( n = 12 mice per group). Log-rank (Mantel-Cox) test. g The percentage of T cells (gated on human CD45 + CD3 + ) in peripheral blood of NOG mice at different time points was determined by flow cytometric analysis. Data are representative of two independent experiments with T-cell from 2 donors ( n = 12 mice per group in total). Mean ± SD, One-way ANOVA with Dunnett’s correction for multiple comparison.

    Journal: Nature Communications

    Article Title: Chimeric antigen receptor T cells targeting FcRH5 provide robust tumour-specific responses in murine xenograft models of multiple myeloma

    doi: 10.1038/s41467-023-39395-4

    Figure Lengend Snippet: a Cytolytic activity of bispecific CAR-T cells and mono-specific CAR-T cells against indicated target cells was determined by the 6-h luciferase-based cytolytic assay. Mean ± SD, n = 3 independent co-cultures. b Bispecific CAR-T cells or mono-specific CAR-T cells were co-incubated with indicated target cells for 24 h, and cell-free supernatants were harvested for evaluating IFN-γ, IL-2 and TNF-α secretion. Mean ± SD, n = 3 independent co-cultures. Experiments of ( a , b ) were repeated with two different T cell donors. c Experimental schematic: Male NOG mice aged 6–8 weeks mice were subcutaneously inoculated with 5 × 10 6 NCI-H929-CBR cells expressing click beetle red (CBR) luciferase on day −7, and were then intravenously infused with 5 × 10 6 mock T, FcRH5 CAR-T, BCMA CAR-T or FcRH5/BCMA CAR-T cells from two different donors ( n = 6 mice per group for each donor) on day 0 when the tumors became palpable. d Representative tumor bioluminescence of NOG mice at different time points. e Graph showed the quantification of whole-body luminescence in NOG mice from each group at different time points with the lines connecting means. Data shown are representative for results obtained in independent experiments with T-cell from 2 donors. Mean ± SD, n = 6 mice per group, One-way ANOVA with Dunnett’s correction for multiple comparison. f Kaplan–Meier curve for the overall survival of mice from different treatment group ( n = 12 mice per group). Log-rank (Mantel-Cox) test. g The percentage of T cells (gated on human CD45 + CD3 + ) in peripheral blood of NOG mice at different time points was determined by flow cytometric analysis. Data are representative of two independent experiments with T-cell from 2 donors ( n = 12 mice per group in total). Mean ± SD, One-way ANOVA with Dunnett’s correction for multiple comparison.

    Article Snippet: The membrane was probed with mouse anti-human CD3ζ mAb (Santa Cruz, catalog number sc-166435, clone: E3, dilution:1:100) or GAPDH mAb (Biolegend, catalog number 649203, clone:FF26A/F9)) followed by incubation with a horseradish peroxidase–conjugated goat anti-mouse IgG antibody (Santa Cruz, catalog number sc-516102, dilution:1:1000) .

    Techniques: Activity Assay, Luciferase, Incubation, Expressing, Comparison

    Assessing the oligomerization state and surface organization of various chimeric antigen receptors in the unstimulated CAR T cell membrane. ( a ) Western blot analysis of HER2.z, HER2.CD28.z, HER2.41BB.z and HER2.CD28.41BB.z CAR T cells. The membranes were probed for anti-human CD3ζ. ( b ) Spot intensities were quantified using ImageJ/Fiji, and the proportion of dimer/oligomer states was determined. ( c ) Representative raw and segmented AiryScan images of fluorescently tagged CARs. Clusters were segregated by watershedding and quantified. The scale bar represents 2 µm. ( d ) Total intensity of the apical membrane slices. ( e ) Average number of clusters per 10 µm 2 apical membrane surface. ( f ) Distribution of individual cluster areas. ( g ) Integrated intensity of individual clusters. The charts represent mean ± SEM; nHER2.z = 54, 4 donors; nHER2.CD28.z = 44, 3 donors; nHER2.41BB.z = 47, 4 donors; nHER2.CD28.41BB.z = 54, 4 donors; * p < 0.05, ** p < 0.01, *** p < 0.001.

    Journal: Cancers

    Article Title: CD28 and 41BB Costimulatory Domains Alone or in Combination Differentially Influence Cell Surface Dynamics and Organization of Chimeric Antigen Receptors and Early Activation of CAR T Cells

    doi: 10.3390/cancers15123081

    Figure Lengend Snippet: Assessing the oligomerization state and surface organization of various chimeric antigen receptors in the unstimulated CAR T cell membrane. ( a ) Western blot analysis of HER2.z, HER2.CD28.z, HER2.41BB.z and HER2.CD28.41BB.z CAR T cells. The membranes were probed for anti-human CD3ζ. ( b ) Spot intensities were quantified using ImageJ/Fiji, and the proportion of dimer/oligomer states was determined. ( c ) Representative raw and segmented AiryScan images of fluorescently tagged CARs. Clusters were segregated by watershedding and quantified. The scale bar represents 2 µm. ( d ) Total intensity of the apical membrane slices. ( e ) Average number of clusters per 10 µm 2 apical membrane surface. ( f ) Distribution of individual cluster areas. ( g ) Integrated intensity of individual clusters. The charts represent mean ± SEM; nHER2.z = 54, 4 donors; nHER2.CD28.z = 44, 3 donors; nHER2.41BB.z = 47, 4 donors; nHER2.CD28.41BB.z = 54, 4 donors; * p < 0.05, ** p < 0.01, *** p < 0.001.

    Article Snippet: The membranes were probed with 1 µg/mL mouse anti-human CD3ζ (Cat.# 556366, BD Biosciences, San Jose, CA, USA) antibody overnight at 4 °C.

    Techniques: Western Blot

    Membrane diffusion analysis and tertiary structure modeling of HER2-specific chimeric antigen receptors. ( a ) Representative fluorescence fluctuation intensity traces of 10-s FCS runs. ( b ) Pooled autocorrelation curve for each CAR. Position of triplet lifetime (τ Triplet ), diffusion correlation times of the detached Alexa Fluor 647 conjugated monomer HER2 ECD (τ A647HER2 ) and the various CAR species (τ. z ; τ. CD28 . z ; τ. 41BB . z ; τ. CD28 . 41BB . z ) are indicated by arrows. ( c ) Diffusion coefficients of CAR constructs. The chart represents mean ± SEM, nHER2.z = 300, 4 donors; nHER2.CD28.z = 260, 3 donors; nHER2.41BB.z = 276, 4 donors; nHER2.CD28.41BB.z = 289, 4 donors; *** p < 0.001. ( d ) Schematic diagram illustrating the tertiary structure of the native TCR and the CAR constructs. TCR: T Cell Receptor complex extracellular domains; CD3z TM: CD3ζ transmembrane segment; CD3z IC: CD3ζ intracellular domain; FRP5 scFv: single chain variable fragment of FRP5 antibody targeting the HER2 ECD; IgG1 SH: short hinge linker derived from IgG1; CD28 TM: transmembrane segment derived from CD28; CD28 IC: costimulatory domain from CD28; 41BB IC: costimulatory domain from 41BB. Confidence scores of the predicted models and intramolecular disulfide bonds are indicated.

    Journal: Cancers

    Article Title: CD28 and 41BB Costimulatory Domains Alone or in Combination Differentially Influence Cell Surface Dynamics and Organization of Chimeric Antigen Receptors and Early Activation of CAR T Cells

    doi: 10.3390/cancers15123081

    Figure Lengend Snippet: Membrane diffusion analysis and tertiary structure modeling of HER2-specific chimeric antigen receptors. ( a ) Representative fluorescence fluctuation intensity traces of 10-s FCS runs. ( b ) Pooled autocorrelation curve for each CAR. Position of triplet lifetime (τ Triplet ), diffusion correlation times of the detached Alexa Fluor 647 conjugated monomer HER2 ECD (τ A647HER2 ) and the various CAR species (τ. z ; τ. CD28 . z ; τ. 41BB . z ; τ. CD28 . 41BB . z ) are indicated by arrows. ( c ) Diffusion coefficients of CAR constructs. The chart represents mean ± SEM, nHER2.z = 300, 4 donors; nHER2.CD28.z = 260, 3 donors; nHER2.41BB.z = 276, 4 donors; nHER2.CD28.41BB.z = 289, 4 donors; *** p < 0.001. ( d ) Schematic diagram illustrating the tertiary structure of the native TCR and the CAR constructs. TCR: T Cell Receptor complex extracellular domains; CD3z TM: CD3ζ transmembrane segment; CD3z IC: CD3ζ intracellular domain; FRP5 scFv: single chain variable fragment of FRP5 antibody targeting the HER2 ECD; IgG1 SH: short hinge linker derived from IgG1; CD28 TM: transmembrane segment derived from CD28; CD28 IC: costimulatory domain from CD28; 41BB IC: costimulatory domain from 41BB. Confidence scores of the predicted models and intramolecular disulfide bonds are indicated.

    Article Snippet: The membranes were probed with 1 µg/mL mouse anti-human CD3ζ (Cat.# 556366, BD Biosciences, San Jose, CA, USA) antibody overnight at 4 °C.

    Techniques: Diffusion-based Assay, Fluorescence, Construct, Derivative Assay

    Early activation signaling events were determined by measuring CD3ζ and Lck phosphorylation. ( a ) Representative microscopic images following 15 min of effector–tumor co-culturing. ( b ) Quantitative image analysis of CD3ζ and Lck phosphorylation. The area of the immune synapse, the average and the integrated intensity of the phospho-specific label in the synapse are plotted showing the distribution of individual data points as well as their mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001.

    Journal: Cancers

    Article Title: CD28 and 41BB Costimulatory Domains Alone or in Combination Differentially Influence Cell Surface Dynamics and Organization of Chimeric Antigen Receptors and Early Activation of CAR T Cells

    doi: 10.3390/cancers15123081

    Figure Lengend Snippet: Early activation signaling events were determined by measuring CD3ζ and Lck phosphorylation. ( a ) Representative microscopic images following 15 min of effector–tumor co-culturing. ( b ) Quantitative image analysis of CD3ζ and Lck phosphorylation. The area of the immune synapse, the average and the integrated intensity of the phospho-specific label in the synapse are plotted showing the distribution of individual data points as well as their mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001.

    Article Snippet: The membranes were probed with 1 µg/mL mouse anti-human CD3ζ (Cat.# 556366, BD Biosciences, San Jose, CA, USA) antibody overnight at 4 °C.

    Techniques: Activation Assay

    Dual peptide CAR-T cell design. (A) Diagram of the CAR construct designs. The E-28t28z and E-8t28z constructs use CD28 and CD8 as the hinge/transmembrane domains respectively, while both constructs employed CD28 for the co-stimulatory domain. The E-28t28z-tCD34 and E-8t28z-tCD34 constructs are identical to the E-28t28z and E-8t28z constructs but feature co-expression of truncated CD34 as an extracellular marker. (B) Diagram of a CAR-T cell with the different dual peptide-based constructs as the antigen-recognition domain. (C) CD34+ expression analysis by flow cytometry allows for a built-in quantification of transduction efficiency. (D) ELISA results displaying IFN-gamma secretion from CAR- or mock-transduced (GFP) T cells co-cultured overnight against T387 GSCs or cell-free media, **** = p < 0.0001. Values shown in the bar chart represent the average of two independent experiments. (E) CD3ζ western blotting with GAPDH as a housekeeping gene, used for additional support to confirm the presence or lack of the CAR following transduction. LTR, Long terminal repeat; S, signal peptide; P2A, Porcine teschovirus-1 2A self-cleaving peptide; tCD34, Truncated CD34.

    Journal: Frontiers in Oncology

    Article Title: Use of phage display biopanning as a tool to design CAR-T cells against glioma stem cells

    doi: 10.3389/fonc.2023.1124272

    Figure Lengend Snippet: Dual peptide CAR-T cell design. (A) Diagram of the CAR construct designs. The E-28t28z and E-8t28z constructs use CD28 and CD8 as the hinge/transmembrane domains respectively, while both constructs employed CD28 for the co-stimulatory domain. The E-28t28z-tCD34 and E-8t28z-tCD34 constructs are identical to the E-28t28z and E-8t28z constructs but feature co-expression of truncated CD34 as an extracellular marker. (B) Diagram of a CAR-T cell with the different dual peptide-based constructs as the antigen-recognition domain. (C) CD34+ expression analysis by flow cytometry allows for a built-in quantification of transduction efficiency. (D) ELISA results displaying IFN-gamma secretion from CAR- or mock-transduced (GFP) T cells co-cultured overnight against T387 GSCs or cell-free media, **** = p < 0.0001. Values shown in the bar chart represent the average of two independent experiments. (E) CD3ζ western blotting with GAPDH as a housekeeping gene, used for additional support to confirm the presence or lack of the CAR following transduction. LTR, Long terminal repeat; S, signal peptide; P2A, Porcine teschovirus-1 2A self-cleaving peptide; tCD34, Truncated CD34.

    Article Snippet: Membranes were incubated with 0.2 μg/mL mouse anti-human CD3ζ (Santa Cruz Biotechnology, SC-166275, Dallas, TX) and 0.04 μg/mL rabbit anti-human glyceraldehyde-3-phosphate dehydrogenase (Santa Cruz Biotechnology, SC-25778, Dallas, TX).

    Techniques: Construct, Expressing, Marker, Flow Cytometry, Transduction, Enzyme-linked Immunosorbent Assay, Cell Culture, Western Blot